Jump to ContentJump to Main Navigation
The Chinese Heroin TradeCross-Border Drug Trafficking in Southeast Asia and Beyond$
Users without a subscription are not able to see the full content.

Ko-lin Chin and Sheldon X. Zhang

Print publication date: 2015

Print ISBN-13: 9781479895403

Published to NYU Press Scholarship Online: March 2016

DOI: 10.18574/nyu/9781479895403.001.0001

Show Summary Details

Drug Treatment with a Chinese Characteristic

Drug Treatment with a Chinese Characteristic

Chapter:
(p.197) 8 Drug Treatment with a Chinese Characteristic
Source:
The Chinese Heroin Trade
Author(s):

Ko-lin Chin

Publisher:
NYU Press
DOI:10.18574/nyu/9781479895403.003.0008

This chapter examines the issues of drug addiction and rehabilitation in China. It explores some of the factors contributing to the rise of addiction in China; discusses how drug users in China are normally treated in compulsory or voluntary drug treatment centers; and explains how repeat drug abusers are often sent to labor education camps for one to three years. It also evaluates the effectiveness of these three treatment regimes and examines some of the new treatment models made available to drug users in China. It is shown that most of the drug abuse problems in China involve opiates, predominantly heroin. While the rates of illicit drug use and associated adverse consequences have continued to escalate across many areas in China, options for effective treatment have remained largely unchanged.

Keywords:   drug use, drug abuse, drug addiction, Chinese drug addicts, drug rehabilitation, China, labor education camps

NYU Press Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs, and if you can't find the answer there, please contact us.